Ticker
TELOCompany Name
TELOMIR PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 481.22K | $ -16.14M | -3353.71% |
3/31/2025 | $ -161.11K | $ -12.52M | 0% |
12/31/2024 | $ 643.04K | $ -16.53M | -2571.04% |
9/30/2024 | $ 442.07K | $ -23.02M | -5207.63% |
6/30/2024 | $ 1.57M | $ -18.74M | -1195.62% |
3/31/2024 | $ 3.02M | $ 0 | 0% |
12/31/2023 | $ 3.54M | $ -13.07M | -369.34% |
9/30/2023 | $ 3.52M | $ 0 | 0% |
12/31/2022 | $ -937.28K | $ -854.15K | 0% |
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for TELOMIR PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -854.15K ] / Inv. Capital [ $ -937.28K ]
(=) ROIC [ 0% ]
Minimum
Sep 30, 2024
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |